Clinical Trials Directory

Trials / Completed

CompletedNCT02069171

Cross-sectional and Questionnaire Study for Leg Lymphedema

The Cross-sectional and Questionnaire Study of Pelvic and Lower Extremity Lymphedema After Treatment of Gynecological Disease

Status
Completed
Phase
Study type
Observational
Enrollment
333 (actual)
Sponsor
National Cancer Center, Korea · Other Government
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to identify the incidence,feature,clinical significance for leg lymphedema after gynecologic cancer treatment.

Detailed description

Medical records will reviewed. And all patients who met the inclusion criteria will contacted by a telephone call by a clinical research coordinator. The telephone interview questionnaire for Lower Extremity Edema (LEE) and gynecologic cancer lymphedema questionnaire (GCLQ) will t take approximately 20-30 min to complete. The questionnaire for LEE included onset, severity, location, duration, and management. Patients will also questioned concerning deep vein thrombosis to exclude other causes of LEE. LEE is defined as subjective edema of lower extremity based on patients' complaint. LLL is defined based on a clinical diagnosis of lymphedema by a physician.

Conditions

Timeline

Start date
2012-06-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2014-02-24
Last updated
2014-02-24

Source: ClinicalTrials.gov record NCT02069171. Inclusion in this directory is not an endorsement.

Cross-sectional and Questionnaire Study for Leg Lymphedema (NCT02069171) · Clinical Trials Directory